Drug class

Nitrogen Mustard Derivatives

Nitrogen mustard derivatives are a foundational class of cytotoxic alkylating antineoplastic agents structurally derived from bis-(2-chloroethyl)amines. Read more about Nitrogen Mustard Derivatives

62 drugs in this class 45 manufacturers

Advertisement

Drugs in Nitrogen Mustard Derivatives

Showing 28–36 of 62 drugs

IFOSFAMIDE

NITROGEN MUSTARD DERIVATIVES · TESTICULAR GERM CELL TUMOR
Hikma Pharmaceuticals USA

MELPHALAN HCL

NITROGEN MUSTARD DERIVATIVES · MULTIPLE MYELOMA
ATHENEX PHARMAC

MELPHALAN HCL

NITROGEN MUSTARD DERIVATIVES · MULTIPLE MYELOMA
MEITHEAL PHARMA

MELPHALAN HCL

NITROGEN MUSTARD DERIVATIVES · MULTIPLE MYELOMA
FOSUN PHARMA US

HEPZATO (melphalan HCl)

NITROGEN MUSTARD DERIVATIVES · UNRESECTABLE HEPATIC METASTATIC UVEAL MELANOMA
DELCATH SYSTEMS
Filter & compare in the drug finder → Opens the drug finder with Nitrogen Mustard Derivatives preselected. Add indication or manufacturer filters there.

About Nitrogen Mustard Derivatives.

Nitrogen mustard derivatives are a foundational class of cytotoxic alkylating antineoplastic agents structurally derived from bis-(2-chloroethyl)amines.

They exert their principal therapeutic effect by forming reactive aziridinium intermediates that covalently bind to DNA bases—chiefly guanine residues—producing intra- and inter-strand cross-links that disrupt replication and transcription, ultimately triggering apoptotic cell death in rapidly dividing cells.

Clinically represented by agents such as cyclophosphamide, chlorambucil, melphalan, ifosfamide, and bendamustine, this class is widely employed in oncology and hematology to treat leukemias, lymphomas, multiple myeloma, and various solid tumors, as well as serving key immunosuppressive roles in conditioning regimens for stem cell transplantation and severe autoimmune disorders.